PTH(1–84) Is Associated With Improved Quality of Life in Hypoparathyroidism Through 5 Years of Therapy

CONTEXT: In hypoparathyroidism, quality of life (QOL) is compromised as compared to normal subjects. We previously reported our results showing an association with recombinant human PTH(1–84) therapy in hypoparathyroidism and improvement in QOL measures for 1 year. OBJECTIVE: We tested the hypothesi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Cusano, Natalie E., Rubin, Mishaela R., McMahon, Donald J., Irani, Dinaz, Anderson, Laura, Levy, Elizabeth, Bilezikian, John P.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Endocrine Society 2014
Gaiak:
Endocrine Care
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4184077/
https://ncbi.nlm.nih.gov/pubmed/24978675
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2014-2267
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak